<DOC>
	<DOCNO>NCT00247364</DOCNO>
	<brief_summary>To define effective dose tolerability levetiracetam individual Restless Legs Syndrome ( RLS ) . It hypothesize levetiracetam well tolerate , safe effective treating symptom RLS .</brief_summary>
	<brief_title>A Double Blind Crossover Trial Levetiracetam ( Keppra® ) Placebo Treatment Restless Legs Syndrome ( RLS )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Psychomotor Agitation</mesh_term>
	<mesh_term>Restless Legs Syndrome</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<criteria>Diagnosed idiopathic RLS accord four IRLSSG diagnostic criterion 1 . An urge move leg , usually accompany cause uncomfortable unpleasant sensation legs . 2 . The urge move unpleasant sensation begin worsen period rest inactivity sit lie . 3 . The urge move unpleasant sensation partially totally relieved movement , walk stretch , least long activity continue 4 . The urge move unpleasant sensation worse even night day occur even night . IRLS Rating Scale score great 15 Baseline visit PLMIndex 5 great first night polysomnography Written inform consent obtain prior study procedure perform . 1 . Women childbearing potential , positive urine pregnancy test lactate screen visit , practice clinically accept method contraception . 2 . Individuals take medication Restless Legs Syndrome without proper washout period 3 . Individuals take hypnotic , sedative , antipsychotic , neuroleptic 4 . History current diagnosis clinically relevant disease may confound assessment RLS symptom ( e.g. , Parkinson ’ disease , dementia , ALS , etc . ) 5 . Subjects serum ferritin 10µg/L 6 . Subjects untreated sleep disorder may confound assessment ( e.g. , narcolepsy , sleep apnea syndrome breathingrelated sleep disorder , REM sleep behaviour disorder ) 7 . Subjects apnea/hypopnea index 15 great initial polysomnography visit 8 . Subjects employ shift work ( e.g. , employment hour disruptive normal circadian sleepwake cycle nighttime variable rotate shift ) 9 . Subjects clinically significant unstable medical condition opinion investigator would render subject unsuitable study ( e.g . severe cardiovascular disease , major depression , psychosis , hepatic renal failure , etc . ) 10. subject positive urine drug test illicit use amphetamine , barbiturate , benzodiazepine , opiate , synthetic narcotic , miscellaneous drug commonly know recreational drug ( e.g. , cannabinoids include THC , heroine , cocaine ) 11 . Participation clinical drug device trial 30 day prior screen visit .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2005</verification_date>
	<keyword>RLS</keyword>
</DOC>